Zylem Biosciences

Zylem Biosciences is a startup biotechnology company developing targeted medicines based on its novel platform technology: A surface chemical mimic of natural high-density lipoprotein (HDL). Zylem has developed a deep pipeline of therapies applicable to diseases and conditions where lipid dysfunction plays a critical role.